The deadline for public comment has expired. Contact the agency or primary contact person listed below for assistance.
Rule Details
Rule Number:
25P004
Title:
Rule 3: Medical Cannabis.
Type:
Standard
Status:
Adopted
Agency:
Vermont Cannabis Control Board
Legal Authority:
7 V.S.A. ยงยง 843(a); 843(b)(1); 843(c)(1); 956; and 974.
Summary:
This is a comprehensive update to rules governing adult-use cannabis establishments and the medical cannabis system. Amendments to Rule 1 streamline renewal; establish siting requirements for retailers; simplify license changes; provide for tier changes based on performance; require deposit accounts; increase flexibility to address past misconduct by applicants; and retire a cumbersome system of prequalification. Amendments to Rule 2 clarify safety standards and allowable use of the Inventory Tracking System; prohibit consignment; standardize transport manifests; disallow illusory brands; standardize warning symbols; provide for product remediation; provide for curbside transactions; implement propagation cultivator licensing; integrate hemp-derived additives; and prohibit cannabinoids in beverage alcohol. Amendments to Rule 3 provide for retailer medical endorsements and raise standards for medical products. Amendments to Rule 4 create a process for orders concerning adulterated products.
Persons Affected:
Medical patients and caregivers; licensees; medical providers; Department of Public Safety, Department of State's Attorneys & Sheriffs; Agency of Agriculture,
Food & Markets; Department of Health; Department of Mental Health; Department of Labor; Division of Fire Safety; Department of Liquor & Lottery; Department of Taxes.
Economic Impact:
This rule will have few broad economic impacts, but it may have economic benefits for medical cannabis patients by increasing competition and access. Vermont has seen predicted atrophy in the medical system, as many registered and prospective patients found adult-use cannabis offerings more accessible and appealing and defected from the dispensary system. This rule implements legislation aimed at improving patient access, and reducing costs of access to patients, by making medical cannabis available for sale through qualified adult-use retailers. To date, medical cannabis has not been subject to the testing and tracking requirements applicable to adult-use cannabis. Cultivators and manufacurers will be impacted by the obligation to pay for product testing for pesticides and pathogens; however, enhnaced confidence in medical products may favorably impact demand.
Posting date:
Jan 15,2025
Hearing Information
Information for Hearing # 1
Hearing date:
Location:
Cannabis Control Board Conference Room
Address:
89 Main Street, 3rd Floor
City:
Montpelier
State:
VT
Zip:
05620-2948
Hearing Notes:
Also virtually via MS Teams at https://www.microsoft.com/en-us/microsoft-teams/join-a-meeting Meeting ID: 219 147 510# Dial in by phone +1 802-828-7667,,219147510 Phone conference ID: 219 147 510#; or by visiting ccb.vermont.gov/event/ccb-rules-hearing.
Meeting ID: 219 147 510# Dial in by phone +1 802-828-7667,,219147510 Phone conference ID: 219 147 510#; or by visiting ccb.ve
State:
VT
Zip:
n/a
Hearing Notes:
Virtually via MS Teams at https://www.microsoft.com/en-us/microsoft-teams/join-a-meeting Meeting ID: 219 147 510# Dial in by phone +1 802-828-7667,,219147510 Phone conference ID: 219 147 510#; or by visiting ccb.vermont.gov/event/ccb-rules-hearing.
